Dr. Shen is a Principal at Essex Woodlands Health Ventures, one of the largest healthcare-focused venture capital firms, where he specializes in investments in biopharmaceutical and medical device companies. He is the U.S. Executive Director of the Singapore Stanford Biodesign Program and a Consulting Assistant Professor of Medicine at Stanford University, teaching courses on medical technology innovation. He has nine patents issued and several pending in the fields of interventional neuroradiology and interventional cardiology.